Infectious Disease & VAccine
At Sterling Analytics, we provide advanced statistical and data science solutions to support clinical trials in infectious diseases. With expertise spanning acute, chronic, and opportunistic infections, our team helps sponsors navigate the complexity of rapidly evolving pathogens, variable patient responses, and urgent regulatory demands.
Whether advancing treatments for emerging threats or chronic infectious diseases, Sterling Analytics ensures reliable, insightful data to accelerate discovery and regulatory success.
Our Areas of Expertise:
🟣 Fungal infections-
Invasive fungal diseases are difficult to diagnose and treat, particularly in immunocompromised populations. We support clinical development of antifungal therapies with tailored statistical approaches for:
   🟡 Candidiasis- including systemic and mucosal forms
   🟡 Aspergillosis- with a focus on pulmonary and disseminated disease
🟣 HIV/AIDS-Â
We bring decades of experience supporting HIV/AIDS trials focused on viral suppression, long-acting therapies, and co-infection management. Our capabilities include:
Time-to-event and longitudinal modeling
Adherence and resistance pattern analysis
Quality of life and patient-reported outcome integration
🟣 COVID-19-Â
Sterling Analytics has been a trusted partner in pandemic-related research, supporting trials in treatment, prevention, and post-acute sequelae of COVID-19. We provide:
Real-world data analytics
Decentralized trial support
Statistical design for adaptive and emergency use trials